Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
138M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
27M
-
Shares change
-
+1.56M
-
Total reported value, excl. options
-
$755M
-
Value change
-
+$43.8M
-
Number of buys
-
42
-
Number of sells
-
-31
-
Price
-
$28.15
Significant Holders of Avidity Biosciences, Inc. - COMMON STOCK (RNA) as of Q3 2020
82 filings reported holding RNA - Avidity Biosciences, Inc. - COMMON STOCK as of Q3 2020.
Avidity Biosciences, Inc. - COMMON STOCK (RNA) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27M shares
of 138M outstanding shares and own 19.6% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4M shares), FMR LLC (3.02M shares), Cormorant Asset Management, LP (2.51M shares), EcoR1 Capital, LLC (2.1M shares), BlackRock Inc. (1.29M shares), FEDERATED HERMES, INC. (1.27M shares), PERCEPTIVE ADVISORS LLC (1.24M shares), Matrix Capital Management Company, LP (1.2M shares), BOXER CAPITAL, LLC (1.12M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (958K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.